NGS Super

Funding rounds backed by NGS Super.

Export CSV
Funding disclosed in full
$123.3M
Median round
$61.6M
Rounds in calculation
2
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Oricell Therapeutics

Develops next-generation cell therapies for oncology and immunology

$110MPre-IPOBiotechChina
8 participantsBeijing Medical and Health Care Industry Investment FundElikon InvestmentE-Town CapitalLuxin Venture CapitalNGS SuperQiming Venture PartnersTalon CapitalVivo Capital
Cauldron Ferm

Provides continuous hyper-fermentation technology for industrial-scale bio-production

$13.3MSeries A2BiotechAustralia
4 participantsHorizons VenturesMain Sequence VenturesNGS SuperSOSV